People's Justice
The Wire · All news

Zantac / Ranitidine (NDMA Cancer)

Search Interest in Zantac Lawsuits and Recalls Spikes Sharply

Published Updated

By People's Justice

What happened

During the week of June 24, 2026, Google Trends recorded major increases in searches related to Zantac recalls, ranitidine, and NDMA — including a 250% week-over-week rise in searches for 'zantac lawsuit attorneys' and 'ndma,' a 130% rise in 'recall on zantac,' and breakout-level growth in 'zantac lawsuit update 2021' and 'zantac lawsuit update 2022.' These trend signals suggest renewed public attention to the ongoing Zantac litigation landscape.

Event date:

Source: trends.google.com

Zantac / Ranitidine (NDMA Cancer) case guideCheck eligibility

Related news

  1. Zantac / Ranitidine (NDMA Cancer)

  2. Zantac / Ranitidine (NDMA Cancer)

    Public Search Interest in Zantac Lawsuit Topics Spikes

    Google Trends data detected sharp increases in searches for terms including 'ranitidine' (up 300%), 'zantac lawsuit attorneys' (up 150%), and 'ndma' (up 170%), along with breakout search activity for 'zantac lawsuit update 2022' and 'recall on zantac,' according to Google Trends.

    Source: trends.google.com

  3. Zantac / Ranitidine (NDMA Cancer)

    MDL 2924 (S.D. Fla., Judge Robin L. Rosenberg) omnibus Daubert order (Doc 6120, 341 pages): ALL defendants' Daubert motions on general causation GRANTED and defendants' summary judgment motion GRANTED — plaintiffs 'fail to produce admissible primary evidence of general causation' that ranitidine causes cancer, ending the federal MDL claims.

    MDL 2924 (S.D. Fla., Judge Robin L. Rosenberg) omnibus Daubert order (Doc 6120, 341 pages): ALL defendants' Daubert motions on general causation GRANTED and defendants' summary judgment motion GRANTED — plaintiffs 'fail to produce admissible primary evidence of general causation' that ranitidine causes cancer, ending the federal MDL claims. Verified from the court order itself.

    Source: gsk.com